Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Treatment Strategies for Glioblastoma
Stanley S. Stylli
Cancers (2020) Vol. 12, Iss. 10, pp. 2883-2883
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Yan Zou, Yajing Sun, Yibin Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
Macarena I. de la Fuente, Howard Colman, Mark Rosenthal, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 1, pp. 146-156
Open Access | Times Cited: 50
Glioblastoma research on zebrafish xenograft models: a systematic review
Alexandra Pliakopanou, Ilias Antonopoulos, Nikolia Darzenta, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 311-325
Open Access | Times Cited: 34
Extracellular vesicles: The key for precision medicine in glioblastoma
Massimiliano Del Bene, Daniela Osti, Stefania Faletti, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 2, pp. 184-196
Open Access | Times Cited: 42
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools
Ilaria Cela, Emily Capone, Gianluca Trevisi, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 25-43
Open Access | Times Cited: 7
New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
Senthilnath Lakshmanachetty, Joselyn Cruz-Cruz, Eric Hoffmeyer, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 893-893
Open Access | Times Cited: 35
Glioma glycolipid metabolism: MSI2–SNORD12B–FIP1L1–ZBTB4 feedback loop as a potential treatment target
Weiwei Dong, Xiaobai Liu, Chunqing Yang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 33
Expert opinion on translational research for advanced glioblastoma treatment
Xiaoteng Cui, Yunfei Wang, Junhu Zhou, et al.
Cancer Biology and Medicine (2023), pp. 1-9
Open Access | Times Cited: 13
Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier
Sanjana Mathew, Matthias Peindl, Philipp Neundorf, et al.
Journal of Neuro-Oncology (2024) Vol. 170, Iss. 1, pp. 67-77
Open Access | Times Cited: 5
ARMC10 Drives Glioblastoma Progression Through Activating Notch Pathway
Bin Feng, Taihong Gao, Lin Chen, et al.
Molecular Carcinogenesis (2025)
Closed Access
The Small Molecules of Plant Origin with Anti-Glioma Activity
Xin Liu, Yin-Xiao Su, Yunmei Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1942-1942
Open Access
Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies
Rawojć Kamila, Mansoor M. Ahmed, Ayesha Mukhtiar, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 508-508
Open Access
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Hong-My Nguyen, Dipongkor Saha
Oncolytic Virotherapy (2021) Vol. Volume 10, pp. 1-27
Open Access | Times Cited: 32
Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review)
Ani-Simona Sevastre, Alexandra Costachi, Ligia Gabriela Tătăranu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 28
The dual role of boron in vitro neurotoxication of glioblastoma cells via SEMA3F/NRP2 and ferroptosis signaling pathways
Fatih Kar, Ceyhan Hacıoğlu, Sedat Kaçar
Environmental Toxicology (2022) Vol. 38, Iss. 1, pp. 70-77
Closed Access | Times Cited: 19
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
Hui-Ju Tseng, Suddhasatwa Banerjee, Bin Qian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115459-115459
Open Access | Times Cited: 11
Therapeutic Effect of Cisplatin-Loaded Polymeric Nanoparticles and Nimotuzumab Combination in Human Glioblastoma Cells
Elif Kağa, Serhat Korkmaz, Sadık Kağa
Research Square (Research Square) (2025)
Closed Access
Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri, et al.
Current Medicinal Chemistry (2021) Vol. 28, Iss. 24, pp. 4877-4892
Open Access | Times Cited: 25
Proline Metabolism in Malignant Gliomas: A Systematic Literature Review
Magdalena Sawicka, Karol Sawicki, Tomasz Łysoń, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2030-2030
Open Access | Times Cited: 16
Transport of nanocarriers to brain for treatment of glioblastoma multiforme: Routes and challenges
Sagar Trivedi, Vidyadevi Bhoyar, Natasha Akojwar, et al.
Nano Trends (2023) Vol. 1, pp. 100005-100005
Open Access | Times Cited: 9
An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care
Velislava Zoteva, Valerie De Meulenaere, Marthe De Boeck, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296360-e0296360
Open Access | Times Cited: 3
Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma
Zhipeng Yang, Yanjie Liu, Haoyuan Li, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 655-665
Closed Access | Times Cited: 3
Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme
Smita Kumari, Pravir Kumar
ACS Omega (2023) Vol. 8, Iss. 11, pp. 10565-10590
Open Access | Times Cited: 8
Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies
Mohammad Salemizadeh Parizi, Fatemeh Salemizadeh Parizi, Saeed Abdolhosseini, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 6, pp. 1613-1624
Closed Access | Times Cited: 18
U3 snoRNA‐mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild‐type glioblastoma cells
Weiwei Dong, Yunhui Liu, Ping Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 10, pp. 2811-2825
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top